UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 315

Sortiert nach

Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

Immunity (Cambridge, Mass.), 2012-09, Vol.37 (3), p.574-587

2012

Link zum Volltext

Verfügbarkeit prüfen

Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1

Cancer cell, 2011-10, Vol.20 (4), p.457-471

2011

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy

Endocrine-related cancer, 2011-10, Vol.18 (5), p.R175-R182

2011

Link zum Volltext

Verfügbarkeit prüfen

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy

Nature (London), 2016-05, Vol.533 (7604), p.547-551

2016

Link zum Volltext

Verfügbarkeit prüfen

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

Nature genetics, 2020-10, Vol.52 (10), p.1011-1017

2020

Link zum Volltext

Verfügbarkeit prüfen

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

Proceedings of the National Academy of Sciences - PNAS, 2014-05, Vol.111 (20), p.7319-7324

2014

Link zum Volltext

Verfügbarkeit prüfen

EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

Science (American Association for the Advancement of Science), 2012-12, Vol.338 (6113), p.1465-1469

2012

Link zum Volltext

Verfügbarkeit prüfen

SOX9 drives WNT pathway activation in prostate cancer

The Journal of clinical investigation, 2016-05, Vol.126 (5), p.1745-1758

2016

Link zum Volltext

Verfügbarkeit prüfen

Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer

Clinical cancer research, 2014-03, Vol.20 (6), p.1590-1600

2014

Link zum Volltext

Verfügbarkeit prüfen

ATM Loss Confers Greater Sensitivity to ATR Inhibition than PARP Inhibition in Prostate Cancer

Cancer research (Chicago, Ill.), 2020-06, Vol.80 (11), p.2094-2100

2020

Link zum Volltext

Verfügbarkeit prüfen

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Clinical cancer research, 2017-07, Vol.23 (14), p.3510-3519

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting the androgen receptor and overcoming resistance in prostate cancer

Current opinion in oncology, 2019-05, Vol.31 (3), p.175

2019

Link zum Volltext

Verfügbarkeit prüfen

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Clinical cancer research, 2017-11, Vol.23 (22), p.6812-6822

2017

Link zum Volltext

Verfügbarkeit prüfen

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

Nature communications, 2021-12, Vol.12 (1), p.7308-7308, Article 7308

2021

Link zum Volltext

Verfügbarkeit prüfen

Galeterone Prevents Androgen Receptor Binding to Chromatin and Enhances Degradation of Mutant Androgen Receptor

Clinical cancer research, 2014-08, Vol.20 (15), p.4075-4085

2014

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

Clinical cancer research, 2015-03, Vol.21 (6), p.1273-1280

2015

Link zum Volltext

Verfügbarkeit prüfen

Castration-resistant prostate cancer: Adaptive responses in the androgen axis

Cancer treatment reviews, 2014-04, Vol.40 (3), p.426-433

2014

Link zum Volltext

Verfügbarkeit prüfen

Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein

Cell reports (Cambridge), 2016-10, Vol.17 (4), p.966-976

2016

Link zum Volltext

Verfügbarkeit prüfen

Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity

Cell reports (Cambridge), 2014-12, Vol.9 (5), p.1618-1627

2014

Link zum Volltext

Verfügbarkeit prüfen

Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2103-2105

2017

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms mediating androgen receptor reactivation after castration

Urologic oncology, 2009, Vol.27 (1), p.36-41

2009

Link zum Volltext

Verfügbarkeit prüfen

Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation

The Journal of biological chemistry, 2012-03, Vol.287 (11), p.8571-8583

2012

Link zum Volltext

Verfügbarkeit prüfen

PTEN-deficient tumors depend on AKT2 for maintenance and survival

Cancer discovery, 2014-08, Vol.4 (8), p.942-955

2014

Link zum Volltext

Verfügbarkeit prüfen

WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7), p.1016-1030

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Englisch
(315)
Japanisch
(76)

Erscheinungsjahr

n.n

Thema

Science & Technology
(201)
Humans
(184)
Life Sciences & Biomedicine
(184)
Male
(136)
Oncology
(86)
Animals
(82)
Mice
(63)
Biological And Medical Sciences
(56)
Cell Line, Tumor
(55)
Prostate Cancer
(54)
Receptors, Androgen - Metabolism
(50)
Receptors, Androgen - Genetics
(49)
Medical Sciences
(45)
Prostatic Neoplasms - Genetics
(44)
Prostatic Neoplasms - Metabolism
(41)
Prostatic Neoplasms - Pathology
(36)
Tumors
(36)
Immunology
(35)
Cancer Research
(33)
Gene Expression Regulation, Neoplastic
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1

Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy

Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

SOX9 drives WNT pathway activation in prostate cancer

Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer

ATM Loss Confers Greater Sensitivity to ATR Inhibition than PARP Inhibition in Prostate Cancer

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Targeting the androgen receptor and overcoming resistance in prostate cancer

Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

Galeterone Prevents Androgen Receptor Binding to Chromatin and Enhances Degradation of Mutant Androgen Receptor

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting

Castration-resistant prostate cancer: Adaptive responses in the androgen axis

Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein

Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity

Association Between Androgen Receptor Splice Variants and Prostate Cancer Resistance to Abiraterone and Enzalutamide

Mechanisms mediating androgen receptor reactivation after castration

Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation

PTEN-deficient tumors depend on AKT2 for maintenance and survival

WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth

Suchergebnisse filtern